An osteopontin/CD44 immune checkpoint controls CD8(+) T cell activation and tumor immune evasion

類似資料

• Loss of Fas Expression and Function is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy
  著者:: Xiao, Wei, 等
  出版事項: (2018)
• Osteopontin Blockade Immunotherapy Increases Cytotoxic T Lymphocyte Lytic Activity and Suppresses Colon Tumor Progression
  著者:: Klement, John D., 等
  出版事項: (2021)
• Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation
  著者:: Moorman, Hannah R., 等
  出版事項: (2020)
• Is CD47 an innate immune checkpoint for tumor evasion?
  著者:: Liu, Xiaojuan, 等
  出版事項: (2017)
• H3K4me3 mediates the NF-κB p50 homodimer binding to the pdcd1 promoter to activate PD-1 transcription in T cells
  著者:: Priscilla S. Redd, 等
  出版事項: (2018-09-01)